The sympathetic neurotransmitter noradrenaline (NA) fully inhibited both phases of glucose-stimulated insulin secretion from rat islets of Langerhans. The secretory response to the protein kinase C (PKC) activator, 4,8-phorbol myristate acetate (4/?PMA), in the absence of exogenous glucose was also abolished by NA. However, at 20 mM glucose 4flPMA partially alleviated the inhibitory effect of NA both on insulin release and on cyclic AMP generation. Inhibition of insulin release by NA, albeit much decreased, was still observed in the presence of maximal stimulatory concentrations of both 4/IPMA and dibutyryl cyclic AMP. The relieving effect of 4,8PMA on the
INTRODUCTION
In recent years many studies have attempted to define the mechanisms by which catecholamines inhibit secretion from pancreatic B-cells, but the precise intracellular signalling pathways with which a2-adrenergic receptors interact are still unclear. Catecholamines are now known to act at several distinct sites within B-cells: early events include the inhibition of glucose metabolism (Laychock and Bilgin, 1987) , inhibition of glucoseinduced electrical activity (Joffre and Debuyser, 1990) , thought to be secondary to activation of low-conductance K+ channels (Rorsman et al., 1991) , and changes in membrane fluxes of K+ and Ca2+ (Bertrand et al., 1989) . a2-Adrenergic agonists also inhibit adenylate cyclase activity of islet homogenates (Howell and Montague, 1973; Kuo et al., 1973) , and the resultant decrease in cyclic AMP generation in islets was proposed to mediate the inhibitory effects of catecholamines (Yamazaki et al., 1982) . More recent studies have indicated that elevations of cyclic AMP alleviate, but do not abolish, the inhibition of insulin secretion by noradrenaline (NA) Tamagawa et al., 1985; Jones et al., 1987) . Another major signalling pathway within B-cells is the phospholipase Cmediated hydrolysis of inositol phospholipids, by which inositol phosphates and diacylglycerol (DAG) are generated (Prentki and Matschinsky, 1987) . Catecholamines are without effect on B-cell inositol phospholipid turnover (Axen et al., 1983; Blachier et al., 1987) , but to our knowledge there have been no reports on the ability of the DAG/protein kinase C (PKC) signal-transduction system to affect the inhibitory capacity of a2 agonists. In the present studies we have therefore assessed the effect ofPKC activation on NA inhibition ofinsulin secretion, and studied the possible interactions between the stimulatory pathways activated by PKC and the inhibitory ones through 
Islet isolation and insulin secretion
Islets of Langerhans were isolated from fed Wistar rats by collagenase digestion of the exocrine pancreas (Bjaaland et al., 1988) . Groups of three islets were incubated at 37°C in 600,ul of a bicarbonate-buffered (pH 7.4) physiological salt solution (Gey and Gey, 1936) supplemented with 2 mM glucose, 2 mM CaCl2, 0.5 mg/ml BSA and test substances of interest. Ascorbic acid (100 ltM) was included to prevent oxidation of NA. In some experiments, islets were preincubated with M) at room temperature for 1 h before addition of test substances and a further incubation for 1 h at 37 'C. Insulin content of the supernatant was determined by radioimmunoassay . For studies of the dynamic regulation of insulin secretion, groups of 100 islets were loaded on to nylon filters (1 am pore Abbreviations used: NA, noradrenaline; PKC, protein kinase C; PMA, phorbol myristate acetate; db cAMP, dibutyryl cyclic AMP; Rp-cAMPS, Rp-adenosine 3',5'-cyclic phosphorothioate; DAG, diacylglycerol; IBMX, 3-isobutyl-1-methylxanthine. size) and perifused (37°C, 1 ml/min) with bicarbonate buffer supplemented with agents of interest. Fractions were collected at 2 min intervals and analysed for insulin content by radioimmunoassay.
PKC down-regulation
In some studies, islet PKC was depleted by prolonged (23 h) exposure to 4,8PMA, as previously described (Persaud et al., 1989b) . Briefly, islets were isolated under aseptic conditions and maintained in RPMI 1640 medium supplemented with 11 mM glucose, 100 ,ug/ml streptomycin, 100 units/ml penicillin, 10 % (v/v) foetal-calf serum and 200 nM 4/JPMA or the inactive analogue, 4aPMA, in a humidified atmosphere ofair/CO2 (19: 1). Islets were harvested before use, and insulin secretion was measured in static incubations, as described above.
Cyclic AMP generation
Groups of 15 freshly isolated islets were incubated for 15 min at 37°C in bicarbonate-buffered salt solution in the presence of 1 mM IBMX and test substances of interest. The islets were pelleted by brief centrifugation (9000 g, 15 s), the supernatant was removed for assay of insulin content, and 400 ,ul of sodium acetate (50 mM, pH 6.2) was added to the islet pellet. Samples were boiled and sonicated (4 x 15 s, 10,am amplitude) before assay of cyclic AMP content (Harper and Brooker, 1975) .
Statistical analysis
All results are expressed as means + S.E.M. Differences between means were analysed by Student's unpaired t tests and considered significant when P < 0.05.
RESULTS
Time course of NA inhibition of insulin secretion Figure 1 shows the effects of NA on the biphasic secretory response of perifused islets to 20 mM glucose. The inhibition of insulin secretion by NA was rapid in onset, such that in islets perifused in the presence of both 20 mM glucose and 10 ,uM NA there was a complete suppression of both first and second phases of the secretory response. Effect of PKC down-regulation on NA inhibition of insulin secretion After islets had been cultured in the presence of 200 nM 4/JPMA for 23 h, an experimental protocol which depletes islet PKC activity (Persaud et al., 1989b) , they responded significantly to 20 mM glucose, and NA completely abolished this secretory response, as it did in the control 4aPMA-treated islets (Table 1) stimulatory concentration, did not further relieve the inhibition by 10 1iM NA (Figure 3a) . The data shown in Figure 2 might suggest two components of the NA inhibitory effect; it is possible that NA is inhibiting secretion in response to glucose alone, while having no effect on the incremental increase due to 4/IPMA. However, this appears not to be the case, because NA can also inhibit insulin release initiated by 4,iPMA (125-500 nM) in the absence of exogenous glucose (Figure 3b ).
Combined effect of db cAMP and 4,BPMA on NA inhibition of insulin release As db cAMP (Jones et al., 1987) and 4/JPMA (Figures 2 and 3) partially relieve NA inhibition of 20 mM glucose-stimulated insulin secretion independently, the effects on secretion of maximal stimulatory concentrations of both agents, in the absence Table 3 Effect of 4fpPMA on NA inhibition of insulin secretion and cyclic
AMP accumulation
Groups of 15 freshly isolated islets were incubated for 15 min in the presence of test agents of interest and 1 mM IBMX, after which time insulin content of the supernatant and cyclic AMP content of the islet pellet were assessed by radioimmunoassay. At 20 mM, glucose stimulated a 2-fold increase in cyclic AMP generation (P < 0.001), and this was significantly (P < 0.001) inhibited by NA (10,uM). 4/3PMA (500 nM) did not significantly increase cyclic AMP (P > 0.2 versus 20 mM glucose), but prevented NA from completely inhibiting cyclic AMP generation (P < 0.001 versus 2 mM glucose), concomitant with a significant alleviation of the inhibitory effect of NA on insulin release (P < 0.001 versus 20 mM glucose + 10 JuM NA).
Values are means+S.E.M. (n = 9-10). secretion in the presence and absence of 10 ,uM NA are similar to those presented in Figures 2 and 3(a) . At 20 mM, glucose stimulated a 2-fold increase in cyclic AMP production, and this was significantly inhibited by NA. 4PfPMA (500 nM) significantly potentiated secretion, and had a small but insignificant stimulatory effect on cyclic AMP accumulation at 20 mM glucose. In the presence of 4/?PMA, the inhibitory effects of NA on both insulin release and cyclic AMP generation were significantly decreased.
Effect of Rp-cAMPS on the alleviation of NA inhibition of insulin secretion by PMA Figure 4 shows the effect of the competitive antagonist of cyclic AMP-dependent protein kinase, Rp-cAMPS (500 ,tM), on the ability of 4/JPMA to relieve NA inhibition of insulin secretion. In the presence of 500 nM 4/IPMA, NA did not exert a full inhibition of glucose-stimulated insulin release, whether or not islets had been preincubated for 1 h with Rp-cAMPS. As expected, RpcAMPS significantly inhibited the potentiation of insulin secretion by the adenylate cyclase activator forskolin, but had no effect on insulin secretion in response to 20 mM glucose alone. Somewhat surprisingly, the stimulatory effect of 4/JPMA at 20 mM glucose was decreased in islets which had been exposed to Rp-cAMPS for 1 h.
DISCUSSION
The well-documented inhibitory effect of NA on glucosestimulated insulin secretion (reviewed by Morgan, 1987 (Jones et al., 1987) . It is unlikely that 4flPMA decreases NA inhibition of secretion in an analogous manner, by maintaining levels of DAG-like material distal to inhibition of phospholipase C activity, because catecholamines do not inhibit phosphoinositide hydrolysis in islets (Axen et al., 1983; Montague et al., 1985; Blachier et al., 1987) .
One possible mechanism of action of 4,#PMA could be a blockade of NA inhibition of adenylate cyclase activity. In human platelets and cyc-lymphoma cells Katada et al., 1985) (Harrison et al., 1984) and electrically permeabilized (Persaud et al., 1990 (Malaisse et al., 1980; Bozem et al., 1987; Thams et al., 1988 The present studies suggest that the activation of PKC has at least two distinct effects on the B-cell secretory mechanism. Thus, in the absence of glucose, the insulin-secretory response to 4,/PMA, like that to stimulatory concentrations of glucose, is totally inhibited by NA. However, in the presence of glucose, 4,BPMA provides protection against the full inhibitory effects of NA which are observed in the presence of either agent individually. The simplest explanation for this is that activation of PKC may be alleviating inhibition of insulin secretion by maintaining levels of a second messenger generated in response to glucose which is normally inhibited by NA. The most obvious candidate, cyclic AMP, has been eliminated by the present experiments, and, in any case, cyclic AMP is not required for glucose-stimulated insulin release (Persaud et al., 1990) . Other second messengers which are increased by glucose, such as Ca2l (Wollheim and Sharp, 1981) or arachidonic acid (Wolf et al., 1986) , must be considered, but further experiments are required to determine whether inhibition of their generation by NA can be relieved by the activation of PKC.
